EZH2 and cholangiocarcinoma: Upregulated SNHG1 could promote cholangiocarcinoma cell proliferation, migration, and cell cycle but reduce apoptosis,121, 122 and the interaction between SNHG1 and EZH2 could target CDKN1A to promote the biological behavior of cholangiocarcinoma.120